Context Therapeutics Inc (CNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,529 | 65,995 | 76,938 | 83,517 | 89,352 |
| TOTAL | $58,517 | $68,354 | $79,059 | $86,948 | $92,731 |
| Non-Current Assets | |||||
| PPE Net | 62 | 30 | 34 | 38 | 42 |
| Other Non-Current Assets | 280 | 110 | 139 | 166 | 193 |
| TOTAL | $342 | $140 | $172 | $204 | $235 |
| Total Assets | $58,859 | $68,494 | $79,231 | $87,152 | $92,966 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,466 | 2,533 | 2,721 | 2,396 | 1,001 |
| Accrued Expenses | 3,909 | 5,375 | 3,196 | 2,045 | 788 |
| TOTAL | $6,534 | $8,020 | $6,036 | $4,555 | $1,900 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 122 | 0 | 21 | 52 | 83 |
| TOTAL | $122 | $N/A | $21 | $52 | $83 |
| Total Liabilities | $6,657 | $8,020 | $6,057 | $4,608 | $1,983 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,879 | 91,879 | 91,879 | 89,704 | 89,704 |
| Common Shares | 92 | 92 | 92 | 90 | 90 |
| Retained earnings | -139,584 | -130,903 | -117,878 | -108,185 | -99,357 |
| TOTAL | $52,202 | $60,474 | $73,174 | $82,544 | $90,983 |
| Total Liabilities And Equity | $58,859 | $68,494 | $79,231 | $87,152 | $92,966 |